"Fitco recruits ideal talents to maximise clients market share with outstanding profit growth"
Summary of Key Rules
Current Employer (Your Company)
Employees (including officers and directors) may not consult about their current employer – regardless of whether the employer is publicly held or privately owned. This prohibition extends to the parent and subsidiaries of an Advisor’s employer.
Under no circumstances may an Advisor ever disclose confidential information about a former employer or any other information that would violate a confidentiality agreement. Furthermore, if an Advisor was previously employed in the finance or accounting department of a company, he/she may not discuss that company until four months after his/her employment has ended. Clients may instruct us to apply additional customized rules concerning former employees.
A consultant may never disclose confidential information obtained in the course of providing consulting services. Consultants must be certain that any services rendered through Fitco-Consulting do not violate any confidentiality agreements entered into with consulting Clients.
Tender Offer & IPOS
An employee (including officers and directors) of a public company that is the target or bidder in a tender offer, or a private company that has filed for an initial public offering, is prohibited from consulting on any topic until the tender offer is resolved.
Competitors / Competitive Intelligence
Advisors may not consult for a Client that is a direct competitor of their employer.
Advisors must abide by the particular rules and regulations of the government entity for which they work. In addition to any restrictions imposed by such rules, Advisors may not consult about the Advisor’s agency, or a matter currently before the agency or known to be coming before the agency. Clients are prohibited from using Fitco-Consulting's services to try to lobby or otherwise influence government officials in any manner related to their office or official duties.
FDA Advisory Committee Members
FDA Advisory Committee Members may not consult about any issue that (i) is before their FDA Committee; (ii) reasonably can be expected to come before their committee; or (iii) about which they are in possession of material nonpublic information.
Customers & Suppliers
Generally, an employee may consult about a company that is a customer or supplier of his/her employer (e.g., about its competitive position, products), in the absence of a confidentiality agreement or other obligation of confidentiality towards the customer or supplier. However, an Advisor may not discuss his/her employer and confidential information concerning its relationship with the customer or supplier (e.g., his/her employer’s purchases or sales to the company).
Clinical Investigators (CIs) may never discuss non-public patient experience information or undisclosed clinical trial results. If not under a confidentiality agreement or otherwise restricted, CIs may generally discuss publicly available information about a trial – e.g., hypotheses about the drug mechanism, design of the study (to the extent published), competitor drugs and developments in the marketplace, doctor’s view of clinical demand, etc. Data Safety Monitoring Board and Clinical Trial Steering Committee members may not discuss current clinical trials.